Clinuvel Pharmaceuticals Limited

ASX:CUV Stock Report

Market Cap: AU$766.1m

Clinuvel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:CUV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Apr 24BuyAU$1,134,874JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany80,349AU$16.18
04 Apr 24SellAU$1,734,906JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany120,306AU$14.42
01 Mar 24BuyAU$2,751,897JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany200,309AU$14.18
01 Mar 24SellAU$2,836,865JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany203,327AU$14.32
23 Feb 24BuyAU$9,140,350JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany587,087AU$18.05
22 Feb 24SellAU$8,419,770JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany519,035AU$18.10
19 Sep 23BuyAU$29,814Philippe WolgenIndividual1,850AU$16.12
26 Jun 23BuyAU$27,147Philippe WolgenIndividual1,532AU$17.72

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CUV?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,351,1636.69%
Individual Insiders6,812,61213.6%
Institutions10,412,52220.8%
General Public29,531,46858.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 40.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.69%
BNY Mellon Asset Management
3,854,042AU$58.9m-10.3%0.01%
6.84%
Philippe Wolgen
3,425,222AU$52.4m9.64%no data
5.17%
Ender I , LLC
2,590,824AU$39.6m0%no data
3.7%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,854,258AU$28.4m291%0.02%
3.48%
Willem Blijdorp
1,743,118AU$26.7m0%no data
3.47%
The Vanguard Group, Inc.
1,738,870AU$26.6m1.87%no data
1.58%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
789,733AU$12.1m-18.5%no data
1.2%
Emilino Group Pty Ltd
603,447AU$9.2m0%no data
1.05%
BlackRock, Inc.
526,676AU$8.1m0.7%no data
0.92%
Dimensional Fund Advisors LP
462,750AU$7.1m-3.83%no data
0.88%
Mark Badcock
440,085AU$6.7m0%no data
0.71%
Norges Bank Investment Management
358,254AU$5.5m-36.7%no data
0.46%
David Trevorrow
229,600AU$3.5m0%no data
0.43%
AllianceBernstein L.P.
217,635AU$3.3m-7.7%no data
0.37%
David Lewis
187,000AU$2.9m0%no data
0.36%
Trent Redding
179,480AU$2.7m0%no data
0.36%
Darren Keamy
178,588AU$2.7m0%no data
0.31%
Rusty Hammer Pty Ltd
156,892AU$2.4m0%no data
0.31%
Dennis Wright
156,874AU$2.4m0%no data
0.29%
Simon Bown
146,000AU$2.2m0%no data
0.23%
Brenda Shanahan
116,577AU$1.8m0%no data
0.17%
Charles Schwab Investment Management, Inc.
85,589AU$1.3m12%no data
0.16%
Brenda Shanahan Charitable Foundation., Endowment Arm
80,000AU$1.2m0%no data
0.14%
Australian Super Pty Ltd
72,635AU$1.1m0%no data
0.12%
State Street Global Advisors, Inc.
61,535AU$940.9k-1.76%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.